In conclusion, we demonstrate that Tregs and CD8+ T cells penetrate retinal tissue in diabetic retinopathy, and low-dose IL-2 increases the Treg:CD8+ T cell ratio and ameliorates vascular damage, indicating its potential as a treatment for diabetic retinopathy. The gene discussed is CD8A; the disease is diabetic retinopathy.